Vaccination Allocation

Chicago Weekly and Cumulative COVID Vaccine Allocations by Manufacturer and Dose 

Data as of June 23, 2021 

Week Dates   Doses Allocated
Dose Pfizer Moderna Janssen
1 12/13/20 - 12/19/20 1 23,400    
2      
2 12/20/20 - 12/26/20 1 38,025 63,000  
2      
3 12/27/20 - 1/2/21 1 16,575 16,100  
2 23,400    
4 1/3/21 - 1/9/21 1 16,575 16,200  
2 16,575    
5 1/10/21 - 1/16/21 1 17,550 17,000  
2 21,450 46,800  
6 1/17/21 - 1/23/21 1 17,550 17,000  
2 16,575 16,200  
7 1/24/21 - 1/30/21 1 17,550 22,400  
2 16,575 16,100  
8 1/31/21 - 2/6/21 1 17,550 24,500  
2 17,550 16,200  
9 2/7/21 - 2/13/21 1 17,550 26,500  
2 17,550 17,000  
10 2/14/21 - 2/20/21 1 30,420 26,500  
2 17,550 17,000  
11 2/21/21 - 2/27/21 1 31,590 26,500  
2 21,060 22,400  
12 2/28/21 - 3/6/21 1 33,930 26,500 22,300
2 21,060 24,500  
13 3/7/21 - 3/13/21 1 36,270 29,900  
2 26,910 26,500  
14 3/14/21 - 3/20/21 1 37,440 26,500 8,300
2 31,590 26,500  
15 3/21/21 - 3/27/21 1 45,630 26,500 15,700
2 33,930 26,500  
16 3/28/21 - 4/3/21 1 37,440 27,700 39,900
2 36,270 27,200  
17 4/4/21 - 4/10/21 1 37,440 27,700 4,800
2 37,440 29,900  
18 4/11/21 -4/17/21 1 40,950 44,900  
2 45,630 26,500  
19 4/18/21 - 4/24/21 1 40,950 29,900  
2 37,440 26,500  
20 4/25/21 - 5/1/21 1 40,950 29,900 6,200
2 37,440 27,700  
21 5/2/21 - 5/8/21 1 40,950 30,600 4,800
2 40,950 27,700  
22 5/9/21 - 5/15/21 1 40,950 30,520  
2 76,050 44,900  
23 5/16/21 - 5/22/21 1 40,950 30,520  
2 40,950 30,200  
24 5/23/21 - 5/29/21 1 40,770 30,520  
2 57,150 29,820  
25 5/30/21 - 6/5/21 1 40,770 30,520  
2 40,770 30,520  
26 6/6/21 - 6/12/21 1 40,770 30,520  
2 40,770 30,520  

27

28

6/13/21 - 6/19/21

6/20/21 - 6/26/21

 1 40,770 30,520  
2 40,770 30,520  
1 40,770 30,520  
2 40,770 30,520  
Cumulative Total Weeks 1-28: 1,776,210 1,417,640 102,000

*Does not include doses allocated to United Center or Federal pharmacy program

*This information is for historical purposes only. As of June 30, 2021, this list is no longer updated. With consistent and dependable supply to meet current and projected demand, the US no longer requires the allocation process for COVID vaccines.